Physician profile
Benjamin K Rhee
NPI 1922041938
$15,212.29
in general payments reported to CMS, 2019-2025
10 companies · $350 in 2025
The $350 reported for 2025 was more than what 77% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $206 · 2021: $14K · 2022: $183 · 2023: $422 · 2024: $217 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,080.85 | 2020-2022 | |
| Coloplast Corp | $463.56 | 2022-2025 | Speedicath, Peristeen |
| Baxter Healthcare | $268.26 | 2023-2025 | Tisseel, Floseal |
| Teleflex LLC | $228.88 | 2024-2025 | Deflux Metal Needle, Urolift |
| Laborie Medical Technologies Corp. | $98.86 | 2023 | |
| Smith+Nephew, INC. | $29.57 | 2021 | |
| Hollister Incorporated | $16.89 | 2023 | Infyna Chic, Vapro Plus Pocket |
| Bolder Surgical LLC | $13.51 | 2021 | |
| Medtronic Vascular, INC. | $11.91 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.